Evoke Pharma, Inc. (NASDAQ:EVOK) Q4 2023 Earnings Call Transcript March 14, 2024 Evoke Pharma, Inc. misses on earnings expectations. Reported EPS is $-0.59 EPS, expectations were $-0.5. Evoke Pharma, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, […]
If I’m looking to outperform the market over time, I’m usually going to buy growth stocks. While value stocks have a place in any portfolio, growth stocks are the ones that keep the returns rolling in. Usually, companies represented by growth stocks are innovative and quickly adapt to changing times. By being involved in some of the most creative industries, such as biotechnology, technology and green energy, growth stocks help you capitalize on emerging trends and technologies. I also like grow